Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis

ConclusionsAchieving pCR after neoadjuvant chemotherapy was associated with clinically meaningful improvements in survival parameters in a real-world setting. The cumulative data support pCR as a valid surrogate endpoint in both clinical trials and population-based settings.

http://link.springer.com/10.1007/s00432-019-03083-y

Source: Journal of Cancer Research and Clinical Oncology - January 28, 2020 Category: Cancer & Oncology Source Type: research